Untitled

Sepsis Alliance* presents…On-demand Training Module: Sepsis & Oncology

Cancer is the most common comorbid condition in patients with sepsis. Cancer patients are particularly susceptible to sepsis due to the immunosuppressive effects of cancer treatment, or due to the malignancy itself. The risk of developing sepsis is increased ten-fold by the presence of any type of cancer, and a sepsis diagnosis in cancer patients increases the risk of death by two to three times. This training module explores the unique complexities of sepsis in the cancer patient, and discusses sepsis screening, identification, and treatment in this population. A case study is included, along with a patient’s experience to provide the patient perspective.

Learning Objectives  |  At the conclusion of this educational activity, the participant should be able to:

• Define sepsis as related to the cancer patient (Knowledge)
• Recognize the importance of understanding sepsis in cancer patient (Knowledge, Competence)
• Describe how sepsis can present in cancer patient (Knowledge)
• Assess the impact of sepsis on cancer care (Knowledge, Competence)
• Articulate considerations for management of sepsis in cancer patients and implement these management techniques in patient care (Knowledge, Competence, Performance, Patient Outcomes)

Presenters:

• Cara Fleming, AGPCNP-BC, AOCNP
• Jeffrey Groeger, M.D.
• Imrana Malik, M.D.

Target audience: Physicians, Nurses, Clinicians & other members of the healthcare team involved in care of cancer patients

Available CE credit:

• 1.00 AMA PRA Category 1 Credit
• 1.00 Participation
• 1.50 RN CE Contact Hours

Questions should be directed to Sepsis Alliance at https://www.sepsisinstitute.org/contact-us

There is no cost for this program.

* NOTE: This is an industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.